Jian-Hui Weng is a notable inventor based in Oro Valley, AZ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the APJ receptor. His work is crucial for addressing health issues related to increased blood pressure.

Latest Patents

Weng holds a patent for "Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators." This invention relates to benzoimidazole-carboxylic acid amide compounds, which are useful in treating diseases associated with elevated blood pressure. The compounds are defined by a specific formula, and they serve as active ingredients in pharmaceutical compositions.

Career Highlights

Jian-Hui Weng is currently employed at Sanofi, a leading global healthcare company. His role involves research and development of innovative pharmaceutical solutions. With 1 patent to his name, Weng has established himself as a key player in the pharmaceutical industry.

Collaborations

Weng has collaborated with notable colleagues, including Stephanie Hachtel and Paulus Wohlfart. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Jian-Hui Weng's work in pharmaceutical modulation highlights his innovative spirit and dedication to improving health outcomes. His contributions are vital in the ongoing fight against diseases related to blood pressure.

Profile summary based on public USPTO records.